Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease

World Journal of Urology

Volumn 30, Issue 6, 2012, Pages 795-799

  Tollefson, Matthew K ^a   Boorjian, Stephen A ^a   Farmer, Sara A ^a   Frank, Igor ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical staging; Pathologic staging; Risk stratification; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; CYSTECTOMY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UROTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84870317909     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0855-8     Document Type: Article

References (29)

1. Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277.
2. Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19: 666.
3. Hollenbeck BK, Miller DC, Dunn RL et al (2005) The effects of stage divergence on survival after radical cystectomy for urothelial cancer. Urol Oncol 23: 77.
4. Shariat SF, Palapattu GS, Karakiewicz PI et al (2007) Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51: 137.
5. McLaughlin S, Shephard J, Wallen E et al (2007) Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer. Int Braz J Urol 33: 25.
6. Mehrsai A, Mansoori D, Taheri Mahmoudi M et al (2004) A comparison between clinical and pathologic staging in patients with bladder cancer. Urol J 1: 85.
7. Ficarra V, Dalpiaz O, Alrabi N et al (2005) Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95: 786.
8. Guzzo TJ, Magheli A, Bivalacqua TJ et al (2009) Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. Urology 74: 1276.
9. deVere White RW, Katz MH, Steinberg GD (2009) The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer. J Urol 181: 1994-1997.
10. Grossman HB, Natale RB, Tangen CM et al (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349: 859.
11. Madersbacher S, Hochreiter W, Burkhard F et al (2003) Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 21: 690.
12. Hotston M, Patel S, Sohail M et al (2006) What is the significance of pT0 at cystectomy? Surg Oncol 15: 65.
13. Isbarn H, Karakiewicz PI, Shariat SF et al (2009) Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer. J Urol 182: 459.
14. Svatek RS, Shariat SF, Lasky RE et al (2010) The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res 16: 4461.
15. Dimopoulos MA, Moulopoulos LA (1998) Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder. J Clin Oncol 16: 1601.
16. Volkmer BG, Kuefer R, Bartsch G Jr et al (2005) Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival. Cancer 104: 2384.
17. Thrasher JB, Frazier HA, Robertson JE et al (1994) Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer? J Urol 152: 393.
18. Herr HW (2001) Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 19: 89.
19. Solsona E, Iborra I, Collado A et al (2010) Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer. J Urol 184: 475.
20. Palapattu GS, Shariat SF, Karakiewicz PI et al (2006) Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol 175: 1645.
21. Yiou R, Patard JJ, Benhard H et al (2002) Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 89: 374.
22. Kassouf W, Spiess PE, Brown GA et al (2007) P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors. Eur Urol 52: 769.
23. Smith DC, Mackler NJ, Dunn RL et al (2008) Phase II trial of paclitaxel, carboplatin and gemcitabine in patients with locally advanced carcinoma of the bladder. J Urol 180: 2384.
24. Sagaster P, Flamm J, Flamm M et al (1996) Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer. Eur J Cancer 32A: 1320.
25. Duggan B, Williamson K (2004) Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?). Curr Opin Urol 14: 277.
26. Cho KS, Seo HK, Joung JY et al (2009) Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. J Urol 182: 2625.
27. Kunju LP, You L, Zhang Y et al (2008) Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. J Urol 180: 1928.
28. Quek ML, Quinn DI, Daneshmand S et al (2003) Molecular prognostication in bladder cancer-a current perspective. Eur J Cancer 39: 1501.
29. Tokunaga H, Shariat SF, Green AE et al (2001) Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens. Int J Radiat Oncol Biol Phys 51: 16.